Original article| Volume 27, ISSUE 1, P17-21, January 2005

Download started.


Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia


      Cystic periventricular leukomalacia (cPVL), the principal ischemic brain injury in premature infants, is characterized by necrosis of the white matter in the periventricular region and the major neuropathology for spastic motor deficits in cerebral palsy or epilepsy. Recent reports strongly suggest that the brain injury associated with cPVL may have already occurred in utero. In this study we searched retrospectively for possible clinical situations related to cPVL to facilitate assessment of optimal management. A total of 201 babies born at gestational ages from 24 to 33 weeks were entered into the study (1992–1997) and examined for involvement of 18 factors in cPVL retrospectively. And psychomotor development was examined at least until 18 months of corrected age. Among 201 premature babies 35 cases were diagnosed as cPVL later developed spastic diplegia. There are 23 cases of preeclampsia, no infant suffering from cPVL. In the univariate analysis, exposure to antenatal indomethacin, cord length ≥40 cm, and a low Apgar score were significantly associated with a 2–3 risk increased of cPVL occurrence, while antenatal magnesium sulfate reduced the risk. Chorioamnionitis was positively correlated with the risk, but did not reach statistical significance. In the multivariate analysis we found the statistical significance in exposure to antenatal indomethacin, a low Apgar score, and antenatal magnesium sulfate. Our results suggested that preeclampsia and antenatal exposure of magnesium sulfate reduced the risk while antenatal exposure of indomethacin and low Apgar score associated with the occurrence of cPVL. These findings support a growing consensus that cPVL is often the result of maternal and fetal factors as well as antenatal treatment.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Maternal and Child Health Division, Children and Families Bureau, Ministry of Health and Welfare, Japan. Maternal and child health statistics of Japan, Tokyo: Kaneda I, Mothers and Children and Family Health Education Group Representative; 2003.

        • Sakamoto S.
        • Terao T.
        How to lower perinatal mortality? Perinatal care in Japan.
        Croat Med J. 1998; 39: 197-207
        • Weindling M.
        Periventricular haemorrhage and periventricular leukomalacia.
        Br J Obstet Gynaecol. 1995; 102: 278-281
        • Verma U.
        • Tejani N.
        • Klein S.
        • Reale M.R.
        • Beneck D.
        • Figueroa R.
        • et al.
        Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate.
        Am J Obstet Gynecol. 1997; 176: 275-281
        • Volpe J.J.
        Neurobiology of periventricular leukomalacia in the premature infant.
        Pediatr Res. 2001; 50: 553-562
        • Hagberg B.
        • Hagberg G.
        • Beckung E.
        • Uvebrant P.
        Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991–94.
        Acta Paediatr. 2001; 90: 271-277
        • Itakura A.
        • Kurauchi O.
        • Hayakawa F.
        • Matsuzawa K.
        • Mizutani S.
        • Tomoda Y.
        Timing of periventricular leukomalacia using neonatal electroencephalography.
        Int J Gynaecol Obstet. 1996; 55: 111-115
        • Okamura M.
        • Itakura A.
        • Kurauchi O.
        • Hayakawa F.
        • Mizutani S.
        • Tomoda Y.
        Fetal heart rate pattern associated with periventricular leukomalacia.
        Int J Gynaecol Obstet. 1997; 56: 13-18
        • Hayakawa F.
        • Okumura A.
        • Kato T.
        • Kuno K.
        • Watanabe K.
        Determination of timing of brain injury in preterm infants with periventricular leukomalacia with serial neonatal electroencephalography.
        Pediatrics. 1999; 104: 1077-1081
        • Okumura A.
        • Hayakawa F.
        • Kato T.
        • Itomi K.
        • Maruyama K.
        • Ishihara N.
        • et al.
        Hypocarbia in preterm infants with periventricular leukomalacia: the relation between hypocarbia and mechanical ventilation.
        Pediatrics. 2001; 107: 469-475
        • Kubota T.
        • Okumura A.
        • Hayakawa F.
        • Kato T.
        • Itomi K.
        • Kuno K.
        • et al.
        Relation between the date of cyst formation observable on ultrasonography and the timing of injury determined by serial encephalography in preterm infants with periventricular leukomalacia.
        Brain Dev. 2001; 23: 390-394
        • Wu Y.W.
        • Colford Jr, J.M.
        Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis.
        J Am Med Assoc. 2000; 284: 1417-1424
        • Clapp J.F.
        • Peress N.S.
        • Wesley M.
        • Mann L.I.
        Brain damage after intermittent partial cord occlusion in the chronically instrumented fetal lamb.
        Am J Obstet Gynecol. 1988; 159: 504-509
        • Kumazaki K.
        • Nakayama M.
        • Sumida Y.
        • Ozono K.
        • Mushiake S.
        • Suehara N.
        • et al.
        Placental features in preterm infants with periventricular leukomalacia.
        Pediatrics. 2002; 109: 650-655
        • Vohr B.R.
        • Allan W.C.
        • Westerveld M.
        • Schneider K.C.
        • Katz K.H.
        • Makuch R.W.
        • et al.
        School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial.
        Pediatrics. 2003; 111: e340-e346
        • Ment L.R.
        • Vohr B.
        • Allan W.
        • Westerveld M.
        • Sparrow S.S.
        • Schneider K.C.
        • et al.
        Outcome of children in the indomethacin intraventricular hemorrhage prevention trial.
        Pediatrics. 2000; 105: 485-491
        • FineSmith R.B.
        • Roche K.
        • Yellin P.B.
        • Walsh K.K.
        • Shen C.
        • Zeglis M.
        Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants.
        Am J Perinatol. 1997; 14: 303-307
        • Canterino J.C.
        • Verma U.L.
        • Visintainer P.F.
        • Figueroa R.
        • Klein S.A.
        • Tejani N.A.
        Maternal magnesium sulfate and the development of neonatal periventricular leukomalacia and intraventricular hemorrhage.
        Obstet Gynecol. 1999; 93: 396-402
        • Nelson K.B.
        • Grether J.K.
        Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants?.
        Pediatrics. 1995; 95: 263-269
        • Mittendorf R.
        • Dambrosia J.
        • Pryde P.G.
        • Lee K.S.
        • Gianopoulos J.G.
        • Besinger R.E.
        • et al.
        Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
        Am J Obstet Gynecol. 2002; 186: 1111-1118
        • Nowak L.
        • Bregestovski P.
        • Ascher P.
        • Herbelt A.
        • Prochiantz A.
        Magnesium gates glutamate-activated channels in mouse central neurons.
        Nature. 1984; 307: 462-465
        • Leviton A.
        • Kuban K.C.
        • Pagano M.
        • Brown E.R.
        • Krishnamoorthy K.S.
        • Allred E.N.
        Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g.
        Obstet Gynecol. 1988; 72: 571-576
        • Gray P.H.
        • O'Callaghan M.J.
        • Mohay H.A.
        • Burns Y.R.
        • King J.F.
        Maternal hypertension and neurodevelopmental outcome in very preterm infants.
        Arch Dis Child Fetal Neonatal Ed. 1998; 79: F88-F93
        • Cooper A.C.
        • Robinson G.
        • Vinson G.P.
        • Cheung W.T.
        • Broughton Pipkin F.
        The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy.
        Placenta. 1999; 20: 467-474
        • Ito M.
        • Itakura A.
        • Ohno Y.
        • Nomura M.
        • Senga T.
        • Nagasaka T.
        • et al.
        Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia.
        J Clin Endocrinol Metab. 2002; 87: 1871-1878